MedPath

Emend

Brand Name: Emend

Generic Name: Aprepitant

Expiring Soon
Registration Number

DR-XY44900

Dosage Form

capsule

Issuance Date

November 19, 2020

Expiry Date

November 27, 2025

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength80mg + 125mg
PackagingIn a box of 1 Alu/Alu Blister Pack containing one (1) 125 mg capsule + two (2) 80 mg capsule

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti Emetic/ Substance P Neurokinin 1 Antagonist
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

AprepitantActive
Monograph: Aprepitant

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform